This HTML5 document contains 129 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n11http://dx.doi.org/10.2165/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n9https://scigraph.springernature.com/pub.10.2165/
n13http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q50743867
rdf:type
wikibase:Item
schema:description
artículo científico publicado en 2009 научни чланак videnskabelig artikel 2009 nî lūn-bûn article scientifique article científic наукова стаття, опублікована в червні 2009 2009年学术文章 2009年學術文章 vedecký článok tudományos cikk scienca artikolo artigo científico scientific article published in June 2009 wetenschappelijk artikel 2009年学术文章 2009년 논문 مقالة علمية نشرت في يونيو 2009 artikulong pang-agham teaduslik artikkel научная статья article scientific 2009年學術文章 מאמר מדעי bài báo khoa học 2009年學術文章 2009年学术文章 artigo científico scientific article published in June 2009 artikel ilmiah 2009年学术文章 naučni članak vitskapeleg artikkel vědecký článek articolo scientifico bilimsel makale научни чланак 2009年學術文章 2009年學術文章 vetenskaplig artikel artigo científico wissenschaftlicher Artikel 2009年の論文 tieteellinen artikkeli 2009年学术文章 vitenskapelig artikkel სამეცნიერო სტატია 2009年学术文章 επιστημονικό άρθρο জুন ২০০৯-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ scientific article published in June 2009 artikull shkencor บทความทางวิทยาศาสตร์ научна статия мақолаи илмӣ articol științific artículu científicu artykuł naukowy
p:P577
wds:Q50743867-54ACC155-A984-44EA-9555-BEEF58086418
wdt:P577
2009-06-01T00:00:00Z
p:P2888
wds:Q50743867-540C7A58-F85F-4163-91DF-7F87B40F2F00
wdt:P2888
n9:01312067-200902020-00006
p:P2860
wds:Q50743867-E64C07DE-C8C8-4F91-B560-2B8C5F28609C wds:Q50743867-F06FF35C-E711-42A9-850B-0596E315FE54 wds:Q50743867-D8C18429-1EE6-4398-8435-8D9BA10D829E wds:Q50743867-BA68B05B-CDB2-4ECF-8C12-E45D04F45C3D wds:Q50743867-C39A7A06-893F-4DFC-91CC-47F75E15A99D wds:Q50743867-AC01B1A3-AD0E-4E52-98A7-2701A343EBC8 wds:Q50743867-ACA070B2-C414-4901-B556-F1D7703FE304 wds:Q50743867-B8021F83-06FA-4DA4-9F8C-F37B8D3B3301 wds:Q50743867-99574536-50A8-4CDA-892D-A63788D0BB32 wds:Q50743867-AB81ECA1-FE29-4B07-B84F-C1707546BDF1 wds:Q50743867-620CF77C-8809-4FDF-AD47-478375B4B77F wds:Q50743867-73B70064-39DE-4D3F-9FDC-57DBFDC81D57 wds:Q50743867-7E64741F-D555-457D-9CEB-2322BEBC227A wds:Q50743867-528B113F-28F2-4172-A107-4A930C60C228 wds:Q50743867-12FE85A0-591A-4F82-A3A3-74AADD5D6DDC wds:Q50743867-1B88D85A-3491-404A-8D0B-59A81DDFFA6F
wdt:P2860
wd:Q40794350 wd:Q40894258 wd:Q74316046 wd:Q22241644 wd:Q72541823 wd:Q74415024 wd:Q36244727 wd:Q46093743 wd:Q29616119 wd:Q35078168 wd:Q28284428 wd:Q34662511 wd:Q34240364 wd:Q35583727 wd:Q35202706 wd:Q40746155
p:P2093
wds:Q50743867-15A3F03E-8BEF-4F28-AF41-88EAF9A424E5 wds:Q50743867-BE99AF3F-8ED1-48EF-BAC2-B139A0EC0EB6 wds:Q50743867-D5FD9537-5CCA-48B6-80A6-EC4263800398 wds:Q50743867-7E7E27FE-0BE8-445F-8755-D634C7347498
wdt:P2093
Siddhesh A Kamat Krithika Rajagopalan Sonalee Agarwal Judith J Stephenson
rdfs:label
Impact of natalizumab on patient-reported outcomes in a clinical practice setting: a cross-sectional survey. Impact of natalizumab on patient-reported outcomes in a clinical practice setting: a cross-sectional survey.
skos:prefLabel
Impact of natalizumab on patient-reported outcomes in a clinical practice setting: a cross-sectional survey. Impact of natalizumab on patient-reported outcomes in a clinical practice setting: a cross-sectional survey.
schema:name
Impact of natalizumab on patient-reported outcomes in a clinical practice setting: a cross-sectional survey. Impact of natalizumab on patient-reported outcomes in a clinical practice setting: a cross-sectional survey.
p:P1476
wds:Q50743867-686BEAFB-8E39-4E76-B2FB-D65DB64CC6C0
wdt:P1476
Impact of natalizumab on patient-reported outcomes in a clinical practice setting: a cross-sectional survey.
p:P304
wds:Q50743867-39FA9D02-6EF8-48B2-B1EC-D0336A840852
wdt:P304
105-112
p:P31
wds:Q50743867-8ECB128F-9294-4F78-B087-1433DFB3FE19
wdt:P31
wd:Q13442814
p:P698
wds:Q50743867-125560F4-D227-4E34-94E2-4C7DF0AFBB65
wdtn:P698
n13:22273086
wdt:P698
22273086
p:P1433
wds:Q50743867-B741D229-6A6D-4395-B37B-70B3D83C3C7B
wdt:P1433
wd:Q7756344
p:P433
wds:Q50743867-3469A7A9-D7D5-44E0-AE83-F856FBA6ED85
p:P478
wds:Q50743867-E03FA489-A428-4CDC-BA12-5BE68AF06BB2
wdt:P433
2
wdt:P478
2
p:P356
wds:Q50743867-D36D03C1-800B-406E-A231-E429055FA23E
wdtn:P356
n11:01312067-200902020-00006
wdt:P356
10.2165/01312067-200902020-00006
p:P6179
wds:Q50743867-BB26BBC4-A088-47F3-A82C-0EB85AA2D18E
wdt:P6179
1010247727